Additional information
Off-white Powder
1190105-66-8
ACI-181306
1-[3?,17?-acetoxy-2?-(pyrrolidin-1-yl)-5?-androstan-16?-yl]-1-(prop-2-enyl)pyrrolidinium bromide
1-[(2?,3?,5?,16?,17?)-3,17-Bis(acetyloxy)-2-(1-pyrrolidinyl)androstan-16-yl]-1-(2-propen-1-yl)-pyrrolidinium bromide
179.5-180.0°C
C34H55BrN2O4
635.72
Ambient
2-8°C
2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide
Neuromuscular blocking agent



			

			
![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)